HDAC and Proteasome Inhibitors Synergize to Activate Pro-Apoptotic Factors in Synovial Sarcoma
about
Therapeutic applications of histone deacetylase inhibitors in sarcoma.Proteasome inhibitors against amelanotic melanoma.Systemic Treatment for Adults with Synovial Sarcoma.Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcoma.AP-1 confers resistance to anti-cancer therapy by activating XIAP.
P2860
HDAC and Proteasome Inhibitors Synergize to Activate Pro-Apoptotic Factors in Synovial Sarcoma
description
2017 nî lūn-bûn
@nan
2017 թուականին հրատարակուած գիտական յօդուած
@hyw
2017 թվականին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
HDAC and Proteasome Inhibitors ...... ic Factors in Synovial Sarcoma
@ast
HDAC and Proteasome Inhibitors ...... ic Factors in Synovial Sarcoma
@en
HDAC and Proteasome Inhibitors ...... ic Factors in Synovial Sarcoma
@nl
type
label
HDAC and Proteasome Inhibitors ...... ic Factors in Synovial Sarcoma
@ast
HDAC and Proteasome Inhibitors ...... ic Factors in Synovial Sarcoma
@en
HDAC and Proteasome Inhibitors ...... ic Factors in Synovial Sarcoma
@nl
prefLabel
HDAC and Proteasome Inhibitors ...... ic Factors in Synovial Sarcoma
@ast
HDAC and Proteasome Inhibitors ...... ic Factors in Synovial Sarcoma
@en
HDAC and Proteasome Inhibitors ...... ic Factors in Synovial Sarcoma
@nl
P2093
P2860
P1433
P1476
HDAC and Proteasome Inhibitors ...... ic Factors in Synovial Sarcoma
@en
P2093
Bertha A Brodin
Kevin B Jones
Neal M Poulin
Ren Jie Yao
T Michael Underhill
Torsten O Nielsen
P2860
P304
P356
10.1371/JOURNAL.PONE.0169407
P407
P577
2017-01-05T00:00:00Z